Rain Therapeutics
Latest round
- Series B
Last raised
- Sep 2020
Total raised
- $91M
Investors
- 8
About Rain Therapeutics
Rain Therapeutics Inc.Founded in 2017 in Newark, US, Rain Therapeutics Inc. specializes in oncological therapeutics.Rain Therapeutics Inc. focuses on developing and commercializing innovative therapies aimed at addressing unmet medical needs in oncology. Their primary offerings include targeted therapeutics specifically designed to inhibit cancer cell growth through unique mechanisms of action. These products target various forms of cancer, including solid tumors, with the goal of improving patient outcomes while minimizing side effects associated with traditional chemotherapies.Rain Therapeutics Inc. generates revenue through direct sales and partnerships with healthcare providers. The company engages in B2B collaborations with healthcare facilities to supply its therapeutics, establishing recurring transactions based on patient needs. While exact pricing structures for its flagship products are proprietary, the company emphasizes the value of its therapies in oncology treatment, supported by contractual agreements detailing pricing and delivery terms.Rain Therapeutics Inc. is planning to enhance its product offerings and expand into new markets.00 mn in November 2022, for clinical development of its pipeline candidates and preparation for commercial launches. Rain Therapeutics aims to enter additional geographic regions targeting broader access to its therapies by the end of 2023. This strategic focus reflects the company's commitment to advancing cancer treatment options and improving the quality of life for patients.
Who invested in Rain Therapeutics
8 investors across 2 rounds
See all investors in Rain Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rain Therapeutics
Who invested in Rain Therapeutics?
Rain Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rain Therapeutics raised?
Rain Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rain Therapeutics last raise money?
Rain Therapeutics's most recent round on record is a Series B, in Sep 2020.
What does Rain Therapeutics do?
Rain Therapeutics is a biotechnology company.
Where is Rain Therapeutics headquartered?
Rain Therapeutics is headquartered in Newark, US.
Which VCs invest in companies like Rain Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rain Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rain Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.